Ottobock SE & Co. KGaA
Ottobock is a family-owned medical technology company and global market leader in prosthetics, orthotics, and exoskeletons, serving patients in 45 countries.
Ottobock SE & Co. KGaA is a family-owned medical technology company and a global market leader in prosthetics, orthotics, and exoskeletons. Founded in Berlin in 1919, the company produces standardized, customizable components and wearable bionic technologies intended to restore mobility and independence. It employs nearly 9,300 people, operates in 45 countries, and reports annual revenue exceeding €1.6 billion.
The company's product history includes several landmark developments. Otto Bock pioneered modular, standardized prosthetic parts that could be combined and customized for each patient - an approach that enabled the treatment of thousands of World War I amputees and helped transform prosthetic care from a craft into an industry. The C-Leg was the world's first microprocessor-controlled knee joint for prosthetic users, and the C-Brace is an orthosis that allows users to descend stairs safely. Ottobock also develops exoskeletons and other wearable bionic technologies.
Technical work spans prosthetics, orthotics, exoskeletons, microprocessor-controlled joint control, human bionics, wearable technology, biomechanics, and mechatronics. Manufacturing facilities are located in Duderstadt, Germany, and exoskeleton development labs are based in Emeryville, California. Beyond products, the company runs a network of approximately 400 patient care centers worldwide that deliver prosthetics and orthotics solutions across the full treatment cycle.
Ottobock remains under the ownership of the Näder family, descendants of its founder. The company describes its founding belief as the idea that every person deserves the freedom to move, and its work spans research and development through to clinical care.